IRIS
MASCOLO, Annamaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.853
AS - Asia 1.781
NA - Nord America 1.493
SA - Sud America 339
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 7.496
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.824
US - Stati Uniti d'America 1.460
SG - Singapore 578
CN - Cina 381
IE - Irlanda 339
VN - Vietnam 285
BR - Brasile 280
IT - Italia 261
HK - Hong Kong 233
GB - Regno Unito 106
DE - Germania 90
KR - Corea 78
IN - India 71
UA - Ucraina 55
JP - Giappone 47
GR - Grecia 27
TR - Turchia 27
AR - Argentina 25
FR - Francia 25
FI - Finlandia 21
ID - Indonesia 20
EC - Ecuador 17
NL - Olanda 16
BD - Bangladesh 15
CA - Canada 15
AT - Austria 12
MX - Messico 12
PL - Polonia 12
CZ - Repubblica Ceca 9
BE - Belgio 7
ES - Italia 7
IQ - Iraq 7
MA - Marocco 7
SC - Seychelles 7
SE - Svezia 7
ZA - Sudafrica 7
SA - Arabia Saudita 5
VE - Venezuela 5
CL - Cile 4
CO - Colombia 4
DK - Danimarca 4
HU - Ungheria 4
LT - Lituania 4
PK - Pakistan 4
RS - Serbia 4
UZ - Uzbekistan 4
AL - Albania 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 7.496
Salva come PNG Salva come JPEG
Città #
Moscow 1.046
Dublin 336
Singapore 296
San Jose 280
Hong Kong 232
Santa Clara 225
Chandler 108
Ashburn 92
Jacksonville 88
Seoul 78
Ho Chi Minh City 76
Hefei 73
Dong Ket 60
Hanoi 60
Beijing 50
Bengaluru 42
Princeton 39
Roxbury 38
Naples 35
Bremen 34
Medford 26
São Paulo 26
Aversa 21
Los Angeles 21
New York 21
Orem 18
Genoa 17
Milan 17
Dallas 15
The Dalles 15
Cambridge 14
Ann Arbor 13
Council Bluffs 13
Wilmington 12
Da Nang 11
London 11
Rome 11
Caserta 10
Rio de Janeiro 10
Amsterdam 9
Nuremberg 9
Boardman 8
Brno 8
Chennai 8
Des Moines 8
Munich 8
Napoli 8
Woodbridge 8
Biên Hòa 7
Brussels 7
Falkenstein 7
Haiphong 7
Jakarta 7
Phủ Lý 7
Warsaw 7
Bologna 6
Düsseldorf 6
Helsinki 6
Nanjing 6
Toronto 6
Belo Horizonte 5
Hanover 5
Istanbul 5
Kunming 5
Quito 5
Redwood City 5
Wroclaw 5
Arezzo 4
Atlanta 4
Auburn Hills 4
Baghdad 4
Brasília 4
Campinas 4
Dhaka 4
Frankfurt am Main 4
Guarulhos 4
Hải Dương 4
Juelsminde 4
Lamezia Terme 4
Mexico City 4
Mumbai 4
Norwalk 4
Padova 4
Salerno 4
Salt Lake City 4
San Francisco 4
Tashkent 4
Acerra 3
Asunción 3
Athens 3
Budapest 3
Buffalo 3
Bến Tre 3
Caivano 3
Changsha 3
Chicago 3
Curitiba 3
Giugliano in Campania 3
Groningen 3
Guangzhou 3
Totale 3.897
Salva come PNG Salva come JPEG
Nome #
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 185
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 180
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? 180
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 177
A case of figurate urticaria by etanercept 163
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 162
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 158
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 156
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 150
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 148
Current and future therapeutic perspective in chronic heart failure 148
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 144
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 144
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 144
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? (Heart Failure Reviews, (2020), 10.1007/s10741-020-09961-9) 138
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 137
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 135
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 133
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 129
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 128
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 127
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 126
The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O 125
Effect of chronic kidney diseases on mortality among digoxin users treated for non-valvular atrial fibrillation: A nationwide register-based retrospective cohort study 123
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis 122
Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature 121
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 119
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 118
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 115
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 115
What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials 113
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 113
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 112
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 112
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 111
Risk of Rhabdomyolysis Associated with Dexmedetomidine Use over the Past 10 Years: Insights from the EudraVigilance Database 111
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 111
Neutral endopeptidase (neprilysin) 106
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 106
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 106
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 105
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 105
Therapeutic strategies to fight COVID-19: Which is the status artis? 105
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 103
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 102
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase ® 101
Renin-angiotensin system and coronavirus disease 2019: A narrative review 101
Endotoxin: Structure Source and Effects 99
Relationship between gender and the effectiveness of montelukast: An Italian/Danish register-based retrospective cohort study 98
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 97
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 96
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 95
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 94
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 94
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 93
The efficacy and the safety of Eltrombopag in pediatric patients with Severe Aplastic Anemia: a systematic review 92
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 91
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 89
Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article 88
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: A Danish nationwide cohort study 88
Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: Nationwide cohort study 87
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 80
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazine 76
Retrospective Analysis of a Real-Life Use of Tixagevimab–Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19 61
Real-world safety comparison of liraglutide and semaglutide in weight management: Insights from European pharmacovigilance data 10
Facts and figures of the compassionate use of onco-hematological drugs from 2016 to 2021: Results from the multicentric observational study Compass-O 8
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System 8
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database 6
Totale 7.623
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.143
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 0 0 0 7 30 63
2021/2022242 2 5 10 2 69 14 8 8 17 13 11 83
2022/2023620 74 28 15 34 53 40 4 26 297 7 25 17
2023/2024331 21 10 19 19 91 16 6 30 28 13 19 59
2024/20251.127 8 24 13 26 165 135 234 95 181 88 78 80
2025/20264.797 204 269 260 249 439 2.580 204 297 180 115 0 0
Totale 7.623